What does a non-response to induction chemotherapy imply in high-risk medulloblastomas?
Jihane AdelonChristelle DufourStéphanie FoulonJulien Masliah PlanchonDavid MeyronnetFranck BourdeautGilles PalenzuelaFanny FouyssacSandra RaimbaultEmilie De CarliSébastien KleinAnne PagnierAnne-Isabelle BertozziAngélique RomeAudrey DavidSylvie ChabaudCecile Faure ConterPublished in: Journal of neuro-oncology (2021)
Patients with post-induction SD may benefit from HDCT and CSI, whereas patients with early PD will require new therapeutic approaches.